Loading...
The Clean Air Act and an international environmental treaty have led to the phaseout of chlorofluorocarbon (CFC)-propelled inhalers by December 31, 2008. This change will have an enormous effect on the estimated 5 to 10 million U.S. children with asthma. Highlights of the FDA Public Health Advisory and news alert include the following:
CFC inhalers are harmful to the environment because they deplete the ozone layer.
Hydrofluoroalkane (HFA)-propelled albuterol inhalers will replace CFC inhalers, and healthcare professionals should transition patients now.
Three HFA albuterol inhalers are approved by the FDA:
— Proair HFA Inhalation Aerosol
— Proventil HFA Inhalation Aerosol
— Ventolin HFA Inhalation Aerosol
One HFA levalbuterol is approved by the F…